RT Journal Article SR Electronic T1 Immune profile of children with post-acute sequelae of SARS-CoV-2 infection (Long Covid) JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2021.05.07.21256539 DO 10.1101/2021.05.07.21256539 A1 Gabriele Di Sante A1 Danilo Buonsenso A1 Cristina De Rose A1 Piero Valentini A1 Francesco Ria A1 Maurizio Sanguinetti A1 Michela Sali YR 2021 UL http://medrxiv.org/content/early/2021/05/10/2021.05.07.21256539.abstract AB There is increasing reporting by patients’ organization and researchers of long covid (or post-acute sequelae of SARS-CoV-2 - PASC), characterized by symptoms such as fatigue, dyspnea, chest pain, cognitive and sleeping disturbances, arthralgia and decline in quality of life. Immune system dysregulation with a hyperinflammatory state, direct viral toxicity, endothelial damage and microvascular injury have been proposed as pathologenic mechanisms. Recently, cohorts of children with PASC have been reported in Italy, Sweden and Russia. However, immunological studies of children with PASC have never been performed.In this study, we documented significant immunologic differences between children that completely recovered from acute infection and those with PASC, providing the first objective laboratory sign of the existence of PASC in children.Competing Interest StatementThe authors have declared no competing interest.Funding Statementnothing to declareAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Comitato Etico Fondazione Universitario Policlinico A. GemelliAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yesdataset is available upon request to the corresponding author